首页> 外文期刊>New Journal of Chemistry >EDTA capped iron oxide nanoparticles magnetic micelles: drug delivery vehicle for treatment of chronic myeloid leukemia and T-1-T-2 dual contrast agent for magnetic resonance imaging
【24h】

EDTA capped iron oxide nanoparticles magnetic micelles: drug delivery vehicle for treatment of chronic myeloid leukemia and T-1-T-2 dual contrast agent for magnetic resonance imaging

机译:EDTA封端的氧化铁纳米粒子磁性胶束:用于治疗慢性粒细胞白血病的药物载体和用于磁共振成像的T-1-T-2双对比剂

获取原文
获取原文并翻译 | 示例
           

摘要

Ethylene diamine tetra acetate ( EDTA) capped Fe3O4 nanoparticles ( NPs) have been synthesized and encapsulated using polymeric micelles. The synthesized Fe3O4/EDTA/P magnetic micelles are used as a vehicle to load the hydrophobic drug imatinib and transfect it in a bone marrow cell-line ( K562) in vitro for the treatment of chronic myeloid leukemia. From FTIR spectroscopy it is established that EDTA coordinates bidentately with the surface Fe ions. From the vibrating sample magnetometry ( VSM) study, the shape of the magnetization curve indicates superparamagnetic behavior in the presence of a magnetic field. The hydrodynamic diameter measured by dynamic light scattering ( DLS) is found to be 440 nm within the upper limit ( 500 nm) required to transfect into the cell. An in vitro drug release kinetics study reveals that approximately 60% of the drug is released at the end of 196 h. Notably, the drug-loaded magnetic micelles display much lower liver accumulation compared to the bare drug, indicating prolonged circulation time and maximum availability at the bone marrow. In vivo magnetic resonance ( MR) imaging conducted on nude mice bearing the synthesized magnetic micelle after i.v. administration reveals excellent imaging capabilities, in dual mode, especially 24 h post-injection. We propose that the longitudinal relaxation ( T-1) of water protons can be induced by mimicking Gd-DTPA chelate chemistry while transverse relaxation ( T-2) can be achieved by controlling the particle size.
机译:乙二胺四乙酸酯(EDTA)封端的Fe3O4纳米颗粒(NPs)已被合成并使用聚合物胶束封装。合成的Fe3O4 / EDTA / P磁性胶束可作为载体,用于加载疏水性药物伊马替尼并将其在体外转染到骨髓细胞系(K562)中,以治疗慢性粒细胞白血病。根据FTIR光谱,可以确定EDTA与表面的Fe离子呈双齿配位。根据振动样品磁力分析(VSM)的研究,磁化曲线的形状表示存在磁场时的超顺磁行为。发现通过动态光散射(DLS)测量的流体动力学直径在转染到细胞所需的上限(500 nm)内为440 nm。一项体外药物释放动力学研究表明,在196小时结束时约有60%的药物被释放。值得注意的是,与裸药相比,载药的磁性胶束显示出低得多的肝脏蓄积,表明延长了循环时间,并在骨髓中具有最大的利用率。静脉注射后,对携带合成磁胶束的裸鼠进行体内磁共振(MR)成像。在双模式下,尤其是注射后24小时,给药显示出卓越的成像能力。我们建议可以通过模拟Gd-DTPA螯合物的化学性质来诱导水质子的纵向弛豫(T-1),而可以通过控制粒径来实现横向弛豫(T-2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号